Demo Data from EDBT 2026 / reviewers in the wild / expert
Anastasia V. Rudik
dblp:48/2155 · also Anastasiya V. Rudik, Anastassia V. Rudik
· DBLP profile ↗
5ranked-venue papers
1as first author
0since 2021 · last 2020
0000-0002-8916-9675ORCID · verified
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 5 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
4 papers |
Bioinformatics and computational biology · 100% |
Topics — the 5 heaviest of 7, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery
computational drug discovery |
0.4 | 1 | 2020 | AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity · Bioinform. 2020 |
Bioinformatics and computational biology › molecular property prediction
quantitative structure-activity relationship modeling |
0.4 | 1 | 2020 | AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity · Bioinform. 2020 |
Bioinformatics and computational biology › molecular informatics › cheminformatics
toxicity prediction |
0.3 | 1 | 2018 | ROSC-Pred: web-service for rodent organ-specific carcinogenicity prediction · Bioinform. 2018 |
Bioinformatics and computational biology › drug discovery
drug metabolism prediction |
0.2 | 1 | 2015 | SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds · Bioinform. 2015 |
Bioinformatics and computational biology › drug discovery › drug metabolism prediction
site of metabolism prediction |
0.2 | 1 | 2015 | SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds · Bioinform. 2015 |
Methods — techniques the papers use, named apart from their topics
PASS · 0.9regression · 0.4classification · 0.4GUSAR · 0.4multilevel neighborhoods of atoms · 0.3bayesian-like approach · 0.3multilevel neighbourhoods of atoms descriptors · 0.2bayesian approach · 0.2leave-one-out cross-validation · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2020 | AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activityabstractMOTIVATION: Identification of new molecules promising for treatment of HIV-infection and HIV-associated disorders remains an important task in order to provide safer and more effective therapies. Utilization of prior knowledge by application of computer-aided drug discovery approaches reduces time and financial expenses and increases the chances of positive results in anti-HIV R&D. To provide the scientific community with a tool that allows estimating of potential agents for treatment of HIV-infection and its comorbidities, we have created a freely-available web-resource for prediction of relevant biological activities based on the structural formulae of drug-like molecules. RESULTS: Over 50 000 experimental records for anti-retroviral agents from ChEMBL database were extracted for creating the training sets. After careful examination, about seven thousand molecules inhibiting five HIV-1 proteins were used to develop regression and classification models with the GUSAR software. The average values of R2 = 0.95 and Q2 = 0.72 in validation procedure demonstrated the reasonable accuracy and predictivity of the obtained (Q)SAR models. Prediction of 81 biological activities associated with the treatment of HIV-associated comorbidities with 92% mean accuracy was realized using the PASS program. AVAILABILITY AND IMPLEMENTATION: Freely available on the web at http://www.way2drug.com/hiv/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Leonid A. Stolbov, Dmitry S. Druzhilovskiy, Anastasia V. Rudik, Dmitry Filimonov, Vladimir Poroikov, Marc C. Nicklaus |
Bioinform. | 3 |
| 2018 | ROSC-Pred: web-service for rodent organ-specific carcinogenicity predictionabstractMotivation: Identification of rodent carcinogens is an important task in risk assessment of chemicals. SAR methods were proposed to reduce the number of animal experiments. Most of these methods ignore information about organ-specificity of tumorigenesis. Our study was aimed at the creation of classification models and a freely available online service for prediction of rodent carcinogens considering the species (rats, mice), sex and tissue-specificity from structural formula of compounds. Results: The data from Carcinogenic Potency Database for 1011 organic compounds evaluated on the standard two-year rodent carcinogenicity bioassay was used for the creation of training sets. Structure-activity relationships models for prediction of rodent organ-specific carcinogenicity were created by PASS software, which was based on Bayesian-like approach and Multilevel Neighborhoods of Atoms descriptors. The average prediction accuracy for training sets calculated by leave-one-out and 10-fold cross-validation was 79 and 78.2%, respectively. Availability and implementation: Freely available on the web at http://www.way2drug.com/ROSC. Contact: [email protected]. Supplementary information: Supplementary data are available at Bioinformatics online. Alexey Lagunin, Anastasia V. Rudik, Dmitry S. Druzhilovskiy, Dmitry Filimonov, Vladimir Poroikov |
Bioinform. | 2 |
| 2018 | Molecular property diagnostic suite for diabetes mellitus (MPDSDM): An integrated web portal for drug discovery and drug repurposing
Anamika Singh Gaur, Selvaraman Nagamani, Karunakar Tanneeru, Dmitry S. Druzhilovskiy, Anastasia V. Rudik, Vladimir Poroikov, G. Narahari Sastry |
J. Biomed. Informatics | 5 |
| 2015 | SOMP: web server for in silico prediction of sites of metabolism for drug-like compoundsabstractUNLABELLED: A new freely available web server site of metabolism predictor to predict the sites of metabolism (SOM) based on the structural formula of chemicals has been developed. It is based on the analyses of 'structure-SOM' relationships using a Bayesian approach and labelled multilevel neighbourhoods of atoms descriptors to represent the structures of over 1000 metabolized xenobiotics. The server allows predicting SOMs that are catalysed by 1A2, 2C9, 2C19, 2D6 and 3A4 isoforms of cytochrome P450 and enzymes of the UDP-glucuronosyltransferase family. The average invariant accuracy of prediction that was calculated for the training sets (using leave-one-out cross-validation) and evaluation sets is 0.9 and 0.95, respectively. AVAILABILITY AND IMPLEMENTATION: Freely available on the web at http://www.way2drug.com/SOMP. Anastasia V. Rudik, Alexander V. Dmitriev, Alexey Lagunin, Dmitry Filimonov, Vladimir Poroikov |
Bioinform. | 1 |
| 2013 | DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formulaabstractSUMMARY: Experimentally found gene expression profiles are used to solve different problems in pharmaceutical studies, such as drug repositioning, resistance, toxicity and drug-drug interactions. A special web service, DIGEP-Pred, for prediction of drug-induced changes of gene expression profiles based on structural formulae of chemicals has been developed. Structure-activity relationships for prediction of drug-induced gene expression profiles were determined by Prediction of Activity Spectra for Substances (PASS) software. Comparative Toxicogenomics Database with data on the known drug-induced gene expression profiles of chemicals was used to create mRNA- and protein-based training sets. An average prediction accuracy for the training sets (ROC AUC) calculated by leave-one-out cross-validation on the basis of mRNA data (1385 compounds, 952 genes, 500 up- and 475 down-regulations) and protein data (1451 compounds, 139 genes, 93 up- and 55 down-regulations) exceeded 0.85. AVAILABILITY: Freely available on the web at http://www.way2drug.com/GE. Alexey Lagunin, Anastasia V. Rudik, Dmitry Filimonov, Vladimir Poroikov |
Bioinform. | 3 |